The Effect of Angiotensin II Receptor Blockers in Patients with Hypertrophic Cardiomyopathy: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials

The Effect of Angiotensin II Receptor Blockers in Patients with Hypertrophic Cardiomyopathy: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials

Angiotensin receptor blocker (ARB) therapy has been evaluated to slow down the disease progression in patients with hypertrophic cardiomyopathy (HCM), but there is scarce evidence available to date. Therefore, our meta-analysis aimed to explore the efficacy of ARB therapy as a potential disease-modi...

Full description

Bibliographic Details
Main Authors: Basel Abdelazeem, Kirellos Said Abbas, Soban Ahmad, Hasan Raslan, Fatma Labieb, Pramod Savarapu
Format: Article
Language:English
Published: IMR Press 2022-04-01
Series:Reviews in Cardiovascular Medicine
Subjects:
hypertrophic cardiomyopathy
angiotensin ii receptor blockers
left ventricular mass
systolic blood pressure
systematic review
meta-analysis
Online Access:https://www.imrpress.com/journal/RCM/23/4/10.31083/j.rcm2304141

Internet

https://www.imrpress.com/journal/RCM/23/4/10.31083/j.rcm2304141

Similar Items